Almirall celebrates 10 years in Mexico.

Almirall Mexico has launched in the past three years, nine products for the treatment of diseases such as irritable bowel syndrome, gastroesophageal reflux and dyspepsia, among others, as well as a dermatological line for the treatment of skin diseases.

Recently, Almirall Mexico has received the distinctive practices transparent company by its ethical commitment.

In the words of Israel García, Director General at Mexico, the success of our releases has consolidated our presence in Mexico after 10 years of continuous growth. Our goal is to continue to offer therapeutic solutions with high added value to Mexican society ”.

Israel Garcia, General Manager of Almirall Mexico.

In order to celebrate this anniversary, pharmaceutical company held a commemorative event in the Museum of Mexico economy, Mexico City, attended, as well as Almirall Mexico team and other members of the company, industry and health sector personalities.

Commitment to innovation and internationalization have allowed the expansion of Almirall around the world. Today, Almirall has 12 members in Europe and Latin America, and their own research drugs are present in 70 countries on five continents.

Almirall

Almirall is an international pharmaceutical company based on innovation and committed to health. With headquarters in Barcelona (Spain), Almirall researches, develops, produces and sells drugs own r & d and licensing with the aim of improving the health and well-being of people.

The therapeutic areas in which concentrates its resources in research are related to the treatment of asthma, COPD (chronic obstructive pulmonary disease), gastrointestinal disorders, psoriasis and other skin complaints forms.

Almirall drugs are now present in more than 70 countries. It has direct presence in Europe and Latin America through subsidiaries 12.